Thiotepa: alkylating agent for chemotherapy
Tepadina (thiotepa) is a cytotoxic treatment for haematological disease and solid tumours....
Jump to:
GPs could help the NHS save £20 billion by following NICE guidance when prescribing treatments for conditions such as heart disease and diabetes, according to a new report by the National Prescribing Centre.
Are you up to date on the latest NICE recommendations? Review your prescribing against our quick-reference guideline summaries:
Daxas (roflumilast) is a PDE4 inhibitor for use as an add-on to...
Tepadina (thiotepa) is a cytotoxic treatment for haematological disease and solid tumours....
Botox (botulinum toxin type A) is the first agent to be specifically...
Mylan has launched Capimune ( ciclosporin ), a new brand of ciclosporin...
Adoport is a new brand of tacrolimus available from Sandoz. The 500...
Metoject (methotrexate) can now be prescribed in children from the age of...
The following products have been discontinued from the UK market this year....
Evolve Plus is an emollient spray containing pure lanolin. The product has...
Patients on simvastatin who find it hard to swallow tablets can now...
Ozurdex is an intravitreal implant containing 700 micograms of dexamethasone. It is...
Patients with rheumatoid arthritis can now be treated with tocilizumab (RoActemra) on...
NICE has approved dronedarone (Multaq) as a second-line treatment for certain patients...
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.